NCT06607458: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Sponsor: Delcath Systems Inc.. Phase: PHASE2. Conditions: Refractory Metastatic Colorectal Cancer